
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>TGME49_255260 - Expression Summary</title>
  <style>
    body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
    h1, h2, h3 { color: #333; }
    table { width: 100%; border-collapse: collapse; margin-bottom: 20px; }
    th, td { border: 1px solid #ddd; padding: 8px; text-align: left; }
    th { background-color: #f4f4f4; }
    img { max-width: 100px; }
    .human-readable { max-width: 50em; }
  </style>
</head>
<body>
  <h1><a href="https://toxodb.org/toxo/app/record/gene/TGME49_255260">TGME49_255260</a> - Extremely High Expression Across Tachyzoites and Bradyzoites with Dramatic Silencing During Sexual Development</h1>
  <div class="human-readable">This gene exhibits <strong>exceptionally high expression</strong> in <i>Toxoplasma gondii</i> asexual stages, consistently ranking in the <strong>98th-99th percentile</strong> across multiple experiments. Key expression patterns include: <ul><li>Peak expression in bradyzoites (2,713 TPM, 99.66th percentile) and tachyzoites (1,593-4,767 TPM)</li><li>Dramatic >400-fold upregulation during oocyst sporulation</li><li>Complete silencing (<3 TPM) in all feline enteroepithelial sexual stages</li><li>Biphasic expression pattern during tachyzoite time courses</li></ul> The consistent high expression in replicating stages and complete repression during sexual development suggests this gene encodes a <strong>critical component of the asexual replication machinery</strong>, possibly involved in DNA replication, cell division, or metabolic processes essential for rapid parasite multiplication but incompatible with sexual differentiation.</div>
  
    <section>
      <h2>Exceptionally High Expression in Bradyzoites and Tissue Cysts</h2>
      <p class="human-readable">The gene shows peak expression levels (758-2,713 TPM, 97th-99th percentile) across multiple bradyzoite experiments, indicating critical importance during chronic infection stages.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_408f2c4cda" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_408f2c4cda&default=1"/></td>
<td>Bradyzoite in vitro Transcriptome (ME49)</td>
<td class="human-readable">This gene shows extremely high expression in <i>Toxoplasma gondii</i> bradyzoites with 2,713 TPM (99.66th percentile), indicating it is one of the most abundantly expressed genes in this developmental stage.</td>
<td>5A</td>
<td>Sibley/Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_dac07dbf93" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_dac07dbf93&default=1"/></td>
<td>Bradyzoite in vivo transcriptome (M4)</td>
<td class="human-readable">This gene shows very high expression in <i>Toxoplasma gondii</i> bradyzoites with 758-766 TPM (97th percentile) in the sense direction and negligible antisense expression.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22021236">Buchholz et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_386bac2860" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_386bac2860&default=1"/></td>
<td>T. gondii during spontaneous differentiation in primary rat brain cells.</td>
<td class="human-readable">This gene shows consistently high expression throughout <i>Toxoplasma gondii</i> differentiation in primary rat brain cells, with highest levels in tachyzoites (~1720 TPM) and sustained high expression (738-878 TPM) across all post-infection timepoints from 1-14 days, ranking in the 97th-98th percentile among all genes.</td>
<td>4A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34610266">Mouveaux et al. 2021</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Biphasic Expression Pattern During Tachyzoite Development</h2>
      <p class="human-readable">Multiple tachyzoite time-course experiments reveal a characteristic biphasic expression pattern with early peaks (2-4 hours), mid-course dips (8-22 hours), and late recovery phases (36-44 hours).</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_78959dea55" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_78959dea55&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (VEG)</td>
<td class="human-readable">This gene shows extremely high expression throughout <i>T. gondii</i> tachyzoite infection with a characteristic biphasic pattern, peaking early at 2 hours post-infection (~2,937 TPM, 99.6th percentile), declining to minimum levels at 8 hours (~1,259 TPM), then recovering to high levels by 44 hours (~2,586 TPM).</td>
<td>5B</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_d5645bc639" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_d5645bc639&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (ME49)</td>
<td class="human-readable">This gene shows high expression throughout the <i>T. gondii</i> tachyzoite time course with a distinctive biphasic pattern, peaking at 2 hours post-infection (2030.54 TPM, 99.15th percentile), declining to its lowest level at 8 hours (818.4 TPM, 97.62nd percentile), then gradually increasing to its highest expression at 44 hours (2879.14 TPM, 99.75th percentile).</td>
<td>4B</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_6529b4f68d" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_6529b4f68d&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (RH)</td>
<td class="human-readable">This gene shows consistently high expression levels across the time course in <i>T. gondii</i> tachyzoites with a notable dip at 22 hours post-infection (2166-2176 TPM) compared to elevated levels at 2 hours (4054 TPM) and 36 hours (4737-4767 TPM), ranking in the 99th percentile throughout the experiment.</td>
<td>4B</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_ef984802b1" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_ef984802b1&default=1"/></td>
<td>Tachyzoite Transcriptome Time Series (GT1)</td>
<td class="human-readable">This gene shows very high expression levels (>1400 TPM, >98th percentile) in <i>T. gondii</i> tachyzoites with a declining temporal pattern from 2 to 8 hours post-infection, followed by a slight recovery at 16 hours.</td>
<td>4B</td>
<td>Gregory</td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Massive Upregulation During Oocyst Sporulation</h2>
      <p class="human-readable">Expression increases over 400-fold from unsporulated to sporulated oocysts, reaching 99th percentile levels and indicating essential roles in sporozoite formation and oocyst maturation.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_72dce52949" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_72dce52949&default=1"/></td>
<td>Oocyst Time Series (M4)</td>
<td class="human-readable">This gene shows dramatic upregulation in <i>Toxoplasma gondii</i> oocysts during sporulation, with expression increasing over 400-fold from day 0 to day 4 and continuing to rise through day 10, reaching the 99th percentile of all genes.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22347997">Fritz/Boothroyd/Gregory</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_173528b522" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_173528b522&default=1"/></td>
<td>Full life-cycle transcriptome of T. gondii</td>
<td class="human-readable">This gene shows extremely high upregulation in sporulated oocysts (2,222 TPM, 99.5th percentile) compared to unsporulated (1.45 TPM) and sporulating (3.33 TPM) oocysts in <i>Toxoplasma gondii</i>, with similarly high expression in tachyzoites and tissue cysts but very low expression in enteroepithelial stages.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/30728393">Ramakrishnan et al.</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Complete Silencing During Sexual Development in Feline Host</h2>
      <p class="human-readable">The gene shows >300-fold downregulation from asexual stages to all feline enteroepithelial stages, representing one of the most dramatic stage-specific repressions observed in the parasite lifecycle.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_e7467c0306" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_e7467c0306&default=1"/></td>
<td>Feline enterocyte, tachyzoite, bradyzoite stage transcriptome</td>
<td class="human-readable">This gene is highly expressed in tachyzoites and bradyzoites (tissue cysts) with >1000 TPM but dramatically downregulated in all feline enteroepithelial developmental stages (EES1-EES5) with <3 TPM, indicating stage-specific repression during sexual development in the definitive host.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/30728393">Hehl, Ramakrishnan et al.</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Strong Stage-Specific Expression Favoring Tachyzoites Over Merozoites</h2>
      <p class="human-readable">Tachyzoites show 355-fold higher expression than merozoites, indicating strong stage-specific upregulation during the rapidly dividing asexual phase compared to the sexual merozoite stage.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_75742b9a0a" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_75742b9a0a&default=1"/></td>
<td>Tachyzoite and merozoite transcriptomes</td>
<td class="human-readable">This gene is highly expressed in <i>T. gondii</i> tachyzoites (1593.51 TPM, 98.97th percentile) but shows minimal expression in merozoites (4.48 TPM, 18.02th percentile), indicating strong tachyzoite-specific upregulation.</td>
<td>5A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/25757795">Hehl et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_45b4123102" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_45b4123102&default=1"/></td>
<td>Merozoite Gene Expression</td>
<td class="human-readable">This gene shows substantially higher expression in <i>Toxoplasma gondii</i> tachyzoites (12.2) compared to merozoites from three different cats (4.36-5.66), indicating significant downregulation during the merozoite stage.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/24885521">Behnke et al.</a></td>
<td>array</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Cell Cycle-Regulated Expression in Synchronized Parasites</h2>
      <p class="human-readable">Expression shows clear periodic regulation during the cell cycle with two peaks (early-mid and late cycle phases) and 2.5-fold differential expression between minimum and maximum levels.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_c1a3dbb014" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_c1a3dbb014&default=1"/></td>
<td>Cell Cycle Expression Profiles (RH)</td>
<td class="human-readable">This gene shows strong cell cycle-regulated expression in <i>T. gondii</i> with lowest levels at the start of the cycle (0 HR, ~11 log2 units) and peak expression during mid-to-late cycle phases (3-5 HR and 11-12 HR, ~13-13.4 log2 units), demonstrating a clear periodic pattern with approximately 2.5-fold differential expression.</td>
<td>4A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/20865045">Behnke et al.</a></td>
<td>array</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Consistent High Expression Across Host Cell Types and Infection Models</h2>
      <p class="human-readable">The gene maintains exceptionally high expression (97th-99th percentile) across diverse host cell types, infection conditions, and parasite strains, indicating constitutive importance during active infection.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_a48cc7c61e" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_a48cc7c61e&default=1"/></td>
<td>Comparative ribosome profiling of intracellular and extracellular parasites</td>
<td class="human-readable">This gene shows markedly higher expression in extracellular <i>Toxoplasma gondii</i> parasites compared to intracellular parasites in RNA-seq data (905.29 vs 483.77 TPM), while ribosome profiling reveals the opposite pattern with higher ribosome occupancy in intracellular parasites (643.16 vs 219.14 TPM).</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/29228904">Hassan et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_930295d0b5" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_930295d0b5&default=1"/></td>
<td>T gondii Transcriptome during infection in 4 mouse cell types</td>
<td class="human-readable">This gene shows differential expression across mouse cell types during <i>T. gondii</i> infection, with highest expression in astrocytes (1190.76 TPM, 99.4th percentile) and lowest in fibroblasts (137.06 TPM, 98.52nd percentile), indicating cell-type-specific regulation during parasitic infection.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/28775382">Swierzy et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_b0427cd47b" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_b0427cd47b&default=1"/></td>
<td>Transcriptome during acute or chronic infection in mouse brain</td>
<td class="human-readable">This gene shows high expression during both acute and chronic <i>Toxoplasma gondii</i> infection in mouse brain, with significantly higher expression during acute infection (1001.33 TPM) compared to chronic infection (663.9 TPM).</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/25240600">Pittman et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_59fb8debdb" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_59fb8debdb&default=1"/></td>
<td>T. gondii during infection in IEC18 cells (Dual RNA-Seq)</td>
<td class="human-readable">This gene shows minimal expression in frozen sporozoite controls (1.14 TPM) but is highly expressed in viable sporozoites (685.41 TPM) and both tachyzoite conditions (~1,025 TPM), indicating strong upregulation during active <i>Toxoplasma gondii</i> infection of rat intestinal epithelial cells.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/28362800">Guiton et al. 2017</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_4362334059" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_4362334059&default=1"/></td>
<td>Parasite transcriptome during infection in mouse brain.</td>
<td class="human-readable">This gene shows dramatically higher expression in <i>Toxoplasma gondii</i> type III strain-infected neurons (221.52 TPM) compared to type II strain-infected neurons (85.65 TPM), with minimal to no expression detected in bystander neurons from either strain.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32878927">Merritt et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_749cb10dcf" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_749cb10dcf&default=1"/></td>
<td>Stage-specific RNA-sequencing in Toxoplasma gondii</td>
<td class="human-readable">This gene is highly expressed in both life cycle stages but shows significant downregulation in bradyzoites (360 TPM) compared to tachyzoites (823 TPM) during <i>Toxoplasma gondii</i> stage conversion.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/31955846">Waldman et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_79e1396920" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_79e1396920&default=1"/></td>
<td>RNA-Seq of MORC WT and MORC KD parasites</td>
<td class="human-readable">This gene shows high baseline expression that is substantially downregulated upon MORC knockdown treatment, with the strongest reduction observed in the RH strain at 24 hours (from ~2200 to ~635 TPM) and more modest reductions in the PRU strain, while FR235222 treatment also causes downregulation.</td>
<td>4B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32094587">Farhat et al.</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
    <section>
      <h2>Other</h2>
      <p class="human-readable">These experiments were not grouped by the AI.</p>
      <table>
        <thead>
          <tr>
            <th>Preview</th>
            <th>Name</th>
            <th>Summary</th>
            <th>Biological Importance</th>
            <th>Attribution</th>
            <th>Assay Type</th>
          </tr>
        </thead>
        <tbody>
    
<tr>
<td><img id="ExpressionGraphs__DS_2750122e82" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_2750122e82&default=1"/></td>
<td>Oocyst, tachyzoite, and bradyzoite developmental expression profiles (M4)</td>
<td class="human-readable">This gene shows dramatic upregulation during oocyst sporulation in <i>Toxoplasma gondii</i>, increasing from low expression in unsporulated oocysts (3.53) to high expression in sporulated oocysts and tachyzoites (9.81-9.88), with moderately high expression maintained in bradyzoites (7.05-8.19).</td>
<td>4A</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22347997">Fritz and Buchholz et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_994d646c6a" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_994d646c6a&default=1"/></td>
<td>Bradyzoite Differentiation (Multiple 6-hr time points and Extended time series)</td>
<td class="human-readable">This gene shows consistently high expression throughout <i>Toxoplasma gondii</i> bradyzoite differentiation, maintaining RMA normalized values between 6.94-11.82 (typically >90th percentile) with peak expression at the earliest time points (0 hours) that gradually decreases but remains elevated.</td>
<td>4B</td>
<td>Davis and Roos et al.</td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_2daab8c933" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_2daab8c933&default=1"/></td>
<td>Bradyzoite Differentiation Expression Profiles (ME49, GT1, CTGara)</td>
<td class="human-readable">This gene shows consistently high expression across all three <i>Toxoplasma gondii</i> strains with modest downregulation during bradyzoite differentiation, particularly under pH 8.2 conditions.</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/18433450">Behnke et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_485e6e94e3" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_485e6e94e3&default=1"/></td>
<td>Transcriptomes of 29 strains during murine macrophage infection</td>
<td class="human-readable">This gene shows consistently high expression across all 29 <i>Toxoplasma gondii</i> strains during murine macrophage infection, with expression values ranging from 754-1838 TPM and percentile rankings consistently above the 97th percentile, indicating constitutive high-level expression without substantial strain-specific variation.</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22847430">Minot et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_4a81d92b98" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_4a81d92b98&default=1"/></td>
<td>RNA-Seq of CPSF4 WT and CPSF4 KD parasites</td>
<td class="human-readable">This gene shows high, stable expression across all conditions in <i>Toxoplasma gondii</i> with a notable increase at 48 hours of CPSF4 knockdown (from ~1800-2000 to ~2800 TPM), suggesting it may be negatively regulated by CPSF4 or subject to indirect effects of CPSF4 depletion.</td>
<td>3B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34263725">Farhat et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_73d06a9e7b" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_73d06a9e7b&default=1"/></td>
<td>Expression profiling of 3 archetypal lineages</td>
<td class="human-readable">This gene shows high expression across all three <i>T. gondii</i> lineages with Type I strains (RH, GT1) showing the highest expression levels, followed by Type III strains (CTG, VEG), and Type II strains (Pru, ME49) showing moderately lower expression.</td>
<td>2B</td>
<td>Davis and Roos, unpublished</td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_d459caa7da" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_d459caa7da&default=1"/></td>
<td>Tachyzoite transcriptome during invasion (RH)</td>
<td class="human-readable">This gene shows high expression levels across all conditions but exhibits a modest downregulation in <i>Toxoplasma gondii</i> tachyzoites at 2 hours post-invasion compared to extracellular and newly invaded parasites.</td>
<td>2B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/21166903">Gaji et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_50943f57a2" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_50943f57a2&default=1"/></td>
<td>Bradyzoite Differentiation (3-day time series)(Pru)</td>
<td class="human-readable">This gene shows modest downregulation during <i>Toxoplasma gondii</i> bradyzoite differentiation, with expression decreasing from day 0 to day 2 and then gradually recovering by day 4, though remaining below initial tachyzoite levels.</td>
<td>2B</td>
<td>Buchholz, Fritz and Boothroyd et al.</td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_35bb13db5b" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_35bb13db5b&default=1"/></td>
<td>Mutants and wild-type expression profiles during bradyzoite differentiation</td>
<td class="human-readable">This gene shows consistently high expression across all conditions with only modest downregulation (0.3-0.4 log2 units) in wild-type bradyzoites compared to tachyzoites, while mutant strains fail to show this normal differentiation-associated decrease.</td>
<td>2B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/21209930">Lescault et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_e8c4cf2187" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_e8c4cf2187&default=1"/></td>
<td>Differential Expression Profiling GCN5-A mutant</td>
<td class="human-readable">This gene shows modest downregulation in response to alkaline stress in both wild-type and GCN5-A knockout <i>Toxoplasma gondii</i> strains, with expression decreasing from ~14.0 to ~13.8 log2 units under stress conditions regardless of genotype.</td>
<td>2B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/21179246">Naguleswaran et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_0d220fc0c6" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_0d220fc0c6&default=1"/></td>
<td>Mouse brain bradyzoite transcriptomes at 28, 90, 120 days post infection</td>
<td class="human-readable">This gene is highly and consistently expressed across all timepoints in <i>Toxoplasma gondii</i> bradyzoites from mouse brain cysts, maintaining stable transcript levels (919-1001 TPM) with consistently high percentile rankings (>98th percentile) at 28, 90, and 120 days post-infection.</td>
<td>2B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/31726967">Garfoot et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_94e899930e" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_94e899930e&default=1"/></td>
<td>Tachyzoite Transcriptome 3 and 4 days post-infection (VEG NcLIV)</td>
<td class="human-readable">This gene shows high and stable expression in <i>T. gondii</i> tachyzoites with only modest upregulation from day 3 to day 4 post-infection (2148 to 2366 TPM for unique reads).</td>
<td>2B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/22457617">Reid et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_3a839edb9c" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_3a839edb9c&default=1"/></td>
<td>Transcriptome of Wild-Type and gra18 mutant strains of T. gondii</td>
<td class="human-readable">This gene shows consistently high expression across all <i>Toxoplasma gondii</i> strains and treatment conditions, with slightly reduced expression in the GRA18 complemented strain compared to wild-type and GRA18 knockout strains.</td>
<td>2B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/30320549">He et al.</a></td>
<td>RNA-Seq</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_1bdad09720" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=Expression&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_1bdad09720&default=1"/></td>
<td>PMRT1 KO, WT and KOCM expression profiles</td>
<td class="human-readable">This gene shows consistently high expression across all conditions in <i>Toxoplasma gondii</i>, with minimal differences between wild-type, PRMT1 knockout, and complement strains (RMA values ~12.3-12.7).</td>
<td>1B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/26838719">El Bissati et al.</a></td>
<td>array</td>
</tr>
<tr>
<td><img id="ExpressionGraphs__DS_95bf119b5c" src="https://toxodb.org/cgi-bin/dataPlotter.pl?project_id=ToxoDB&&id=TGME49_255260&type=RNASeq&fmt=png&template=1&h=35&w=70&compact=1&datasetId=DS_95bf119b5c&default=1"/></td>
<td>RNA-seq of tartrolon E-treated T. gondii RH parasites</td>
<td class="human-readable">This gene shows consistently high expression levels (>1000 TPM) across all treatment conditions and time points in <i>Toxoplasma gondii</i>, with minimal differential response to tartrolon E treatment compared to controls.</td>
<td>1B</td>
<td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32738587">Bowden et al. 2020</a></td>
<td>RNA-Seq</td>
</tr>
        </tbody>
      </table>
    </section>
  
</body>
<footer>
<p>Generated by the <a href="https://github.com/VEuPathDB/expression-shepherd">Expression Shepherd</a> at commit <a href="https://github.com/VEuPathDB/expression-shepherd/commit/32699ea" target="_blank">32699ea</a> on Sat Jul 19 2025 14:08:22 GMT+0100 (British Summer Time)</p>
</footer>
</html>
  